Get the Stockscreener App
15.04
8.12%
-1.33
After Hours:
15.02
-0.02
-0.13%
Rapport Therapeutics Inc stock is traded at $15.04, with a volume of 206.37K.
It is down -8.12% in the last 24 hours and up +6.29% over the past month.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
See More
Previous Close:
$16.37
Open:
$15.53
24h Volume:
206.37K
Relative Volume:
1.06
Market Cap:
$548.93M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.47%
1M Performance:
+6.29%
6M Performance:
+110.35%
1Y Performance:
-25.69%
1-Day Range:
$14.84
$16.98
1-Week Range:
$14.80
$17.99
52-Week Range:
$7.13
$29.74
Rapport Therapeutics Inc Stock (RAPP) Company Profile
Name
Rapport Therapeutics Inc
Sector
Industry
Phone
857-321-8020
Address
99 HIGH STREET, BOSTON
Compare RAPP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
15.04 | 597.47M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Initiated | H.C. Wainwright | Buy |
| Apr-08-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jul-02-24 | Initiated | Jefferies | Buy |
| Jul-02-24 | Initiated | Stifel | Buy |
| Jul-02-24 | Initiated | TD Cowen | Buy |
Rapport Therapeutics Inc Stock (RAPP) Latest News
Is this a good reentry point in Rapport Therapeutics Inc.July 2025 Final Week & Verified Momentum Stock Watchlist - Newser
Short interest data insights for Rapport Therapeutics Inc.Buy Signal & Safe Capital Investment Plans - Newser
Earnings visualization tools for Rapport Therapeutics Inc.Portfolio Growth Summary & High Conviction Buy Zone Picks - Newser
Analyzing drawdowns of Rapport Therapeutics Inc. with statistical toolsEarnings Beat & Long-Term Growth Stock Strategies - Newser
Best data tools to analyze Rapport Therapeutics Inc. stockBuy Signal & Accurate Buy Signal Notifications - Newser
Should you wait for a breakout in Rapport Therapeutics Inc.July 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
Is Rapport Therapeutics Inc. stock a value trap2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - khodrobank.com
What moving averages say about Rapport Therapeutics Inc.July 2025 Fed Impact & Smart Investment Allocation Tips - Newser
How to monitor Rapport Therapeutics Inc. with trend dashboardsPortfolio Gains Report & Accurate Buy Signal Notifications - Newser
Will Rapport Therapeutics Inc. outperform the market2025 Dividend Review & Stepwise Trade Execution Plans - Newser
Real time scanner hits for Rapport Therapeutics Inc. explained2025 Key Lessons & Low Risk High Win Rate Stock Picks - Newser
Is Rapport Therapeutics Inc. reversing from oversold territory2025 Investor Takeaways & Weekly Top Gainers Alerts - Newser
Why Rapport Therapeutics Inc. is moving todayMarket Performance Report & Growth Focused Investment Plans - Newser
Using RSI to spot recovery in Rapport Therapeutics Inc.Weekly Loss Report & Consistent Return Investment Signals - Newser
Can Rapport Therapeutics Inc. continue delivering strong returnsMarket Activity Recap & Weekly Setup with ROI Potential - khodrobank.com
Is Rapport Therapeutics Inc. stock poised for growthLayoff News & Weekly Top Stock Performers List - Newser
Candlestick signals on Rapport Therapeutics Inc. stock todayJuly 2025 Intraday Action & Short-Term Trading Alerts - Newser
Evaluating Rapport Therapeutics Inc. with trendline analysisBond Market & Weekly High Potential Stock Alerts - Newser
Analyst Calls: Is now the right time to enter Rapport Therapeutics Inc.Earnings Trend Report & AI Powered Trade Plan Recommendations - khodrobank.com
What are Rapport Therapeutics Inc.’s growth leversInsider Selling & Short-Term High Return Ideas - khodrobank.com
Fed Watch: Can Rapport Therapeutics Inc. withstand a market correction2025 Technical Patterns & Growth Focused Entry Reports - khodrobank.com
Analyzing Rapport Therapeutics Inc. with multi timeframe charts2025 Big Picture & Short-Term High Return Strategies - Newser
Bank Watch: How does Rapport Therapeutics Inc. compare to its peersTrade Ideas & Technical Buy Zone Confirmations - khodrobank.com
How does Rapport Therapeutics Inc. compare to its peersPortfolio Risk Summary & AI Forecast Swing Trade Picks - khodrobank.com
What is Rapport Therapeutics Inc. s 5 year growth outlookWeekly Gains Report & Safe Entry Zone Identification - khodrobank.com
Visual trend scoring systems applied to Rapport Therapeutics Inc.Market Performance Summary & Risk Managed Trade Strategies - Newser
What’s the fair value of Rapport Therapeutics Inc. stockEarnings Risk Report & Fast Gaining Stock Strategy Reports - خودرو بانک
Measuring Rapport Therapeutics Inc.’s beta against major indicesEntry Point & Short-Term Trading Opportunity Alerts - Newser
Is it time to cut losses on Rapport Therapeutics Inc.2025 Year in Review & Verified Stock Trade Ideas - Newser
Backtesting results for Rapport Therapeutics Inc. trading strategiesTrade Ideas & Risk Controlled Swing Trade Alerts - Newser
Ranking Rapport Therapeutics Inc. among high performing stocks via toolsJuly 2025 Spike Watch & Growth Focused Stock Reports - Newser
Rapport Therapeutics Inc Stock (RAPP) Financials Data
There is no financial data for Rapport Therapeutics Inc (RAPP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.14%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):